Publications by authors named "Kin-Pan Au"

Article Synopsis
  • The article talks about how to treat peripancreatic fluid collections (PFC).
  • It mentions three ways to help: percutaneous drainage, endoscopy, and surgery.
  • Each method has its pros and cons, and doctors should choose the best one based on the patient’s needs and their own skills.
View Article and Find Full Text PDF

We review the anatomical limits of living donor liver transplantation. Graft size is the fundamental challenge in partial liver transplantation. Insufficient graft size leads to small-for-size syndrome, graft failure, and graft loss.

View Article and Find Full Text PDF

It is uncertain whether tumour biology affects radical treatment for post-transplant hepatocellular carcinoma (HCC) oligo-recurrence, i.e. recurrence limited in numbers and locations amendable to radical therapy.

View Article and Find Full Text PDF

Background: The impact of three-dimensional (3D) visualization on laparoscopic hepatectomy for hepatocellular carcinoma is largely unknown.

Methods: A retrospective review with propensity-score matched analysis of 3D and two-dimensional (2D) laparoscopic hepatectomy performed in a tertiary hepatobiliary surgery center.

Results: Since the availability of 3D laparoscopy, the proportion of laparoscopic major hepatectomies has significantly expanded (1.

View Article and Find Full Text PDF

Background: Magnetic resonance (MR) elastography and proton density fat fraction (PDFF) are emerging techniques for non-invasive assessment of liver stiffness and steatosis, respectively. We investigated the role of MR metrics in pre-treatment prognostication of hepatocellular carcinoma (HCC).

Methods: Patients with newly diagnosed HCC were prospectively recruited.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers wanted to see if immunotherapy (a type of treatment) is safe and works well for patients who had a liver transplant and then got liver cancer again.
  • They looked at information from different studies and found that about 32% of the patients had issues with their body rejecting the new liver after getting immunotherapy.
  • The study suggests that the risk of rejection is a big problem when using immunotherapy after a liver transplant, so more research is needed to understand why this happens.
View Article and Find Full Text PDF

Unlabelled: Precise staging is essential in the management of patients with recurrent hepatocellular carcinoma (HCC) after liver transplantation. There is no current consensus on the optimal staging strategy. We conducted this study to evaluate the performance of dual-tracer positron emission tomography-computed tomography (PET-CT) for this purpose and to investigate whether the results of dual-tracer PET-CT affected patient management.

View Article and Find Full Text PDF
Article Synopsis
  • The study looked at 144 patients who had liver cancer come back after a liver transplant to see if different treatments helped them live longer.
  • They found that patients who got a "radical" treatment (more aggressive) lived longer than those who received "palliative" care (less intense).
  • The results showed that the 50 patients who had the radical treatment survived for about 31 months on average, while those who had the palliative treatment only survived about 19 months.
View Article and Find Full Text PDF
Article Synopsis
  • Some people get liver cancer again after getting a liver transplant, and it's hard to treat.
  • A study looked at using a special radiation treatment called SBRT to help these patients.
  • The results showed SBRT is safe and can work well, with many patients seeing good responses without serious side effects.
View Article and Find Full Text PDF

Background: Mammalian target of rapamycin (mTOR) inhibitors have been shown to reduce the risk of tumour recurrence after liver transplantation for hepatocellular carcinoma (HCC). However, their role in established post-transplant HCC recurrence is uncertain.

Aim: To investigate whether mTOR inhibitor offers a survival benefit in post-transplant HCC recurrence.

View Article and Find Full Text PDF

Since its introduction in 2012, associating liver partition with portal vein ligation for staged hepatectomy (ALPPS) has significantly expanded the pool of candidates for liver resection. It offers patients with insufficient liver function a chance of a cure. ALPPS is most controversial when its high morbidity and mortality is concerned.

View Article and Find Full Text PDF

A large number of liver transplants have been performed for hepatocellular carcinoma (HCC), and recurrence is increasingly encountered. The recurrence of HCC after liver transplantation is notoriously difficult to manage. We hereby propose multi-disciplinary management with a systematic approach.

View Article and Find Full Text PDF

Introduction: Transcutaneous laryngeal ultrasound (TLUSG) is an innovative, non-invasive tool in detecting post-thyroidectomy vocal cord palsy (VCP). However, TLUSG failed to detect about 6-15% laryngoscopic examination (LE)-confirmed VCP. It is unclear whether the outcome of patients with VCP missed by TLUSG [false negative (FN)] is different from those with VCP diagnosed by TLUSG [true positive (TP)].

View Article and Find Full Text PDF

Minimally invasive surgery potentially reduces operative morbidities. However, pure laparoscopic approaches to donor hepatectomy have been limited by technical complexity and concerns over donor safety. Reduced-wound donor hepatectomy, either in the form of a laparoscopic-assisted technique or by utilizing a mini-laparotomy wound, .

View Article and Find Full Text PDF

Background: Chronic hepatitis B virus (HBV) infection is associated with a lower incidence of colorectal liver metastases. We explored the impact of HBV carrier status on outcomes of surgical treatment of colorectal liver metastases.

Methods: A retrospective analysis was conducted for consecutive patients undergoing liver resection for colorectal liver metastases from 2000 to 2016.

View Article and Find Full Text PDF

Objective: To study the correlations and discrepancies between Child-Pugh system and indocyanine green (ICG) clearance test in assessing liver function reserve and explore the possibility of combining two systems to gain an overall liver function assessment.

Design: Retrospective analysis of 2832 hepatocellular carcinoma (HCC) patients graded as Child-Pugh A and Child-Pugh B with ICG clearance test being performed was conducted.

Results: ICG retention rate at 15 minutes (ICG15) correlates with Child-Pugh score, however, with a large variance.

View Article and Find Full Text PDF

Introduction: Patients with hoarseness of voice, previous neck operation, or suspicion of malignancy are at high risk of having pre-thyroidectomy vocal cord (VCP) palsy. Therefore, vocal cord (VC) functions should be evaluated before surgery. This study aimed to evaluate the accuracy of hoarseness, a voice-related questionnaire (Voice Handicap Index [VHI]-30), and transcutaneous laryngeal ultrasound (TLUSG) in diagnosing VCP, as well as the role of TLUSG in the evaluation of high-risk patients.

View Article and Find Full Text PDF

Transcutaneous laryngeal ultrasonography (TLUSG) is a promising alternative to laryngoscopy in vocal cords (VCs) assessment which might be challenging in the beginning. However, it remains unclear when an assessor can provide proficient TLUSG enough to abandon direct laryngoscopy . Eight surgical residents (SRs) without prior USG experience were recruited to determine the learning curve.

View Article and Find Full Text PDF

Background: With improvements in survival, liver transplant recipients now suffer more morbidity from long-term immunosuppression. Considerations were given to develop individualized immunosuppression based on their risk of rejection.

Method: We retrospectively analyzed the data of 788 liver transplants performed during the period from October 1991 to December 2011 to study the relationship between acute cellular rejection (ACR) and various clinical factors.

View Article and Find Full Text PDF

Our aim was to study the long-term outcomes of living donor liver transplantation using small-for-size (SFS) grafts. From July 2002 to July 2009, 233 patients received a right liver graft with a middle hepatic vein from a living donor in our center. Recipients were stratified according to the graft weight to recipient standard liver volume (GW/SLV) ratio into 4 groups: >50% (n = 89), >40% to 50% (n = 85), >35% to 40% (n = 38), and ≤ 35% (n = 21).

View Article and Find Full Text PDF